Pekka Kohonen

Karolinska Institutet

Papers

1

Total Citations

25

H-Index

1

About

Pekka Kohonen is a leading researcher at the intersection of cancer biology and toxicology, with a particular focus on developing alternative, non-animal methods for safety assessment. His work bridges fundamental mechanistic discovery with applied toxicological science, emphasizing how insights from cancer research—especially regarding cellular pathways and molecular targets—can revolutionize how we evaluate chemical hazards. Kohonen’s most cited paper, “Cancer Biology, Toxicology and Alternative Methods Development Go Hand‐in‐Hand” (2014, 25 citations), articulates a visionary framework: that the same technologies driving cancer drug discovery, such as high-content screening and omics, can be repurposed to create more human-relevant, predictive toxicology tools. This integrative approach has positioned him as a key voice in the movement toward 21st-century toxicology, where mechanistic understanding replaces traditional animal tests. His work demonstrates that breakthroughs in one field can catalyze progress in another, making his research not only highly cited but also influential in shaping regulatory science and ethical research practices. For students and researchers, Kohonen exemplifies how interdisciplinary thinking can solve complex biomedical challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Cancer Biology, Toxicology and Alternative Methods Development Go Hand‐in‐Hand
25 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Karolinska Institutet

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago